"mesothelioma" - Google News

Study Shows Perioperative Immunotherapy Safe and Effective for Operable Mesothelioma Patients - Mesothelioma.net

Fri, 29 May 2026 12:49:00 GMT

Study Shows Perioperative Immunotherapy Safe and Effective for Operable Mesothelioma Patients Mesothelioma.net

Top Mesothelioma Signs & Symptoms (2026) - Sokolove Law

Tue, 12 May 2026 07:00:00 GMT

Top Mesothelioma Signs & Symptoms (2026) Sokolove Law

What You Should Know About Mesothelioma in Younger Patients - Memorial Sloan Kettering Cancer Center

Tue, 31 Mar 2026 07:00:00 GMT

What You Should Know About Mesothelioma in Younger Patients Memorial Sloan Kettering Cancer Center

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients - University of Miami

Tue, 05 May 2026 07:00:00 GMT

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients University of Miami

What patients should know after a mesothelioma diagnosis: Medical, emotional and practical next steps - Medical News Bulletin

Fri, 29 May 2026 17:13:04 GMT

What patients should know after a mesothelioma diagnosis: Medical, emotional and practical next steps Medical News Bulletin

Mesothelioma in Younger Patients: Doctors Want to Know Why - Mesothelioma Center

Mon, 20 Apr 2026 07:00:00 GMT

Mesothelioma in Younger Patients: Doctors Want to Know Why Mesothelioma Center

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models | Scientific Reports - Nature

Wed, 25 Feb 2026 08:00:00 GMT

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models | Scientific Reports Nature

J&J Gets Trial Win In Oklahoma Talc Mesothelioma Case - Law360

Thu, 28 May 2026 19:07:00 GMT

J&J Gets Trial Win In Oklahoma Talc Mesothelioma Case Law360

Pleural Mesothelioma Cancer | Signs, Stages & Treatment (2026) - Sokolove Law

Tue, 12 May 2026 07:00:00 GMT

Pleural Mesothelioma Cancer | Signs, Stages & Treatment (2026) Sokolove Law

Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma - Nature

Mon, 27 Apr 2026 07:00:00 GMT

Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma Nature

Mesothelioma and Veterans | VA Benefits and Healthcare - Mesothelioma.net

Wed, 08 Apr 2026 07:00:00 GMT

Mesothelioma and Veterans | VA Benefits and Healthcare Mesothelioma.net

Mesothelioma Prognosis | Stage 1 to Stage 4 Survival Rates (2026) - Sokolove Law

Tue, 12 May 2026 07:00:00 GMT

Mesothelioma Prognosis | Stage 1 to Stage 4 Survival Rates (2026) Sokolove Law

Candidate biomarkers to identify mesothelioma patients at risk of developing venous thromboembolism post-surgery - Nature

Mon, 16 Feb 2026 08:00:00 GMT

Candidate biomarkers to identify mesothelioma patients at risk of developing venous thromboembolism post-surgery Nature

What Is the Mesothelioma Lawsuit About in 2026? - Sokolove Law

Mon, 18 May 2026 07:00:00 GMT

What Is the Mesothelioma Lawsuit About in 2026? Sokolove Law

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study - Nature

Mon, 27 Apr 2026 07:00:00 GMT

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study Nature

Mesothelioma Settlements | $1 Million+ Average Payouts - Sokolove Law

Wed, 06 May 2026 07:00:00 GMT

Mesothelioma Settlements | $1 Million+ Average Payouts Sokolove Law

Fibroblast-like cells in mesothelioma can derive from tumor cells | Cell Death & Differentiation - Nature

Tue, 16 Dec 2025 08:00:00 GMT

Fibroblast-like cells in mesothelioma can derive from tumor cells | Cell Death & Differentiation Nature

Mesothelioma Statistics 2026 | Cases & Death Rates - Sokolove Law

Tue, 12 May 2026 07:00:00 GMT

Mesothelioma Statistics 2026 | Cases & Death Rates Sokolove Law

Genomic sequencing of multicystic mesothelioma finds cohesin complex mutations associated with disease recurrence in patients referred for cytoreductive surgery and HIPEC - Nature

Sat, 14 Mar 2026 07:00:00 GMT

Genomic sequencing of multicystic mesothelioma finds cohesin complex mutations associated with disease recurrence in patients referred for cytoreductive surgery and HIPEC Nature

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models - Nature

Wed, 11 Feb 2026 08:00:00 GMT

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models Nature

A histomorphological atlas of resected mesothelioma discovered by self-supervised learning from 3446 whole-slide images - Nature

Tue, 07 Oct 2025 07:00:00 GMT

A histomorphological atlas of resected mesothelioma discovered by self-supervised learning from 3446 whole-slide images Nature

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients - Mount Sinai

Thu, 12 Feb 2026 14:58:40 GMT

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients Mount Sinai

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses - Nature

Mon, 08 Sep 2025 07:00:00 GMT

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses Nature

BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities - Nature

Wed, 07 Jan 2026 08:00:00 GMT

BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities Nature

A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing - Nature

Fri, 21 Nov 2025 08:00:00 GMT

A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing Nature

Talcum Baby Powder, Asbestos, and Mesothelioma - Mesothelioma.net

Wed, 07 Jan 2026 08:00:00 GMT

Talcum Baby Powder, Asbestos, and Mesothelioma Mesothelioma.net

19 Celebrities & Famous People with Mesothelioma (2026) - Sokolove Law

Mon, 09 Feb 2026 08:00:00 GMT

19 Celebrities & Famous People with Mesothelioma (2026) Sokolove Law

$1M mesothelioma research to examine why some tumors are less invasive - University of Hawaii System

Tue, 14 Apr 2026 07:00:00 GMT

$1M mesothelioma research to examine why some tumors are less invasive University of Hawaii System

Beyond Asbestos: Malignant Pleural Mesothelioma Revealing Lynch Syndrome Through Mismatch Repair Deficiency - The Cureus Journal of Medical Science

Wed, 14 Jan 2026 08:00:00 GMT

Beyond Asbestos: Malignant Pleural Mesothelioma Revealing Lynch Syndrome Through Mismatch Repair Deficiency The Cureus Journal of Medical Science

Mount Sinai Study Supports Lung-Sparing Mesothelioma Surgery - Mesothelioma Center

Tue, 03 Mar 2026 08:00:00 GMT

Mount Sinai Study Supports Lung-Sparing Mesothelioma Surgery Mesothelioma Center

UH Cancer Center identifies treatable form of mesothelioma - University of Hawaii System

Tue, 30 Sep 2025 07:00:00 GMT

UH Cancer Center identifies treatable form of mesothelioma University of Hawaii System

Mesothelioma and Smoking - Mesothelioma.net

Thu, 30 Oct 2025 07:00:00 GMT

Mesothelioma and Smoking Mesothelioma.net

Yearly Recap: 2025 Mesothelioma Research Advances - Mesothelioma.com

Wed, 14 Jan 2026 08:00:00 GMT

Yearly Recap: 2025 Mesothelioma Research Advances Mesothelioma.com

Surgeon Details First North American PITAC for Mesothelioma - Mesothelioma Center

Mon, 30 Mar 2026 07:00:00 GMT

Surgeon Details First North American PITAC for Mesothelioma Mesothelioma Center

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma - Johns Hopkins Medicine

Mon, 08 Sep 2025 07:00:00 GMT

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Johns Hopkins Medicine

Webinar Recap: Surgery for Pleural Mesothelioma - Mesothelioma Center

Sat, 07 Mar 2026 08:00:00 GMT

Webinar Recap: Surgery for Pleural Mesothelioma Mesothelioma Center

Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma - OncLive

Sun, 19 Oct 2025 07:00:00 GMT

Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma OncLive

New Mesothelioma Treatments and Research - Mesothelioma.net

Wed, 01 Apr 2026 07:00:00 GMT

New Mesothelioma Treatments and Research Mesothelioma.net

Primary diffuse malignant epithelioid peritoneal mesothelioma of the greater omentum in an asbestos-naive patient: a case report - Frontiers

Mon, 09 Mar 2026 16:48:08 GMT

Primary diffuse malignant epithelioid peritoneal mesothelioma of the greater omentum in an asbestos-naive patient: a case report Frontiers

Dying from Mesothelioma - Mesothelioma.net

Wed, 24 Sep 2025 07:00:00 GMT

Dying from Mesothelioma Mesothelioma.net

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap - Mesothelioma Center

Thu, 12 Feb 2026 08:00:00 GMT

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap Mesothelioma Center

Mortality Rate on Age, Gender and Race - Mesothelioma Center

Thu, 07 Aug 2025 07:00:00 GMT

Mortality Rate on Age, Gender and Race Mesothelioma Center

Second-Line Pembrolizumab Plus Lenvatinib in Pleural Mesothelioma - The ASCO Post

Wed, 03 Dec 2025 08:00:00 GMT

Second-Line Pembrolizumab Plus Lenvatinib in Pleural Mesothelioma The ASCO Post

VT3989 Demonstrates Antitumor Activity and Tolerability in Refractory Mesothelioma - The ASCO Post

Mon, 20 Oct 2025 07:00:00 GMT

VT3989 Demonstrates Antitumor Activity and Tolerability in Refractory Mesothelioma The ASCO Post

Data from two novel TEAD inhibitors provide the first evidence for the efficacy and safety of targeted treatments in mesothelioma - ESMO Daily Reporter

Wed, 29 Oct 2025 07:00:00 GMT

Data from two novel TEAD inhibitors provide the first evidence for the efficacy and safety of targeted treatments in mesothelioma ESMO Daily Reporter

Still Teaching, Still Healing: Michael Riso’s Mesothelioma Story - Mesothelioma Center

Mon, 13 Apr 2026 07:00:00 GMT

Still Teaching, Still Healing: Michael Riso’s Mesothelioma Story Mesothelioma Center

Mesothelioma Blood Test, Pre-Surgery Immunotherapy Offer Hope - Mesothelioma Center

Tue, 16 Sep 2025 07:00:00 GMT

Mesothelioma Blood Test, Pre-Surgery Immunotherapy Offer Hope Mesothelioma Center

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies - Wiley

Fri, 24 Oct 2025 07:00:00 GMT

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies Wiley

A Mesothelioma Story of Hope: Walking Out on Her Own Two Feet - Mesothelioma Center

Mon, 27 Apr 2026 07:00:00 GMT

A Mesothelioma Story of Hope: Walking Out on Her Own Two Feet Mesothelioma Center

COVID-19 and Mesothelioma | Increased Risk, Precautions - Mesothelioma.net

Wed, 17 Sep 2025 07:00:00 GMT

COVID-19 and Mesothelioma | Increased Risk, Precautions Mesothelioma.net

Recap: International Symposium on Malignant Mesothelioma 2025 - Mesothelioma.com

Tue, 18 Nov 2025 08:00:00 GMT

Recap: International Symposium on Malignant Mesothelioma 2025 Mesothelioma.com

Possible New Treatments for Pleural Mesothelioma - Worldwide Cancer Research

Wed, 19 Nov 2025 05:31:42 GMT

Possible New Treatments for Pleural Mesothelioma Worldwide Cancer Research

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands - Nature

Wed, 16 Jul 2025 07:00:00 GMT

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands Nature

ONCOS-102 for Malignant Mesothelioma - Mesothelioma Guide

Fri, 30 Jan 2026 08:00:00 GMT

ONCOS-102 for Malignant Mesothelioma Mesothelioma Guide

Mesothelioma: My life changed in an instant after terminal diagnosis - BBC

Thu, 19 Feb 2026 08:00:00 GMT

Mesothelioma: My life changed in an instant after terminal diagnosis BBC

Mesothelioma Awareness Day 2025 - Mesothelioma.com

Wed, 24 Sep 2025 07:00:00 GMT

Mesothelioma Awareness Day 2025 Mesothelioma.com

Mesothelioma and the Navy - Mesothelioma Guide

Fri, 30 Jan 2026 08:00:00 GMT

Mesothelioma and the Navy Mesothelioma Guide

Breakthrough discovery reveals treatable form of familial mesothelioma - News-Medical

Tue, 02 Sep 2025 07:00:00 GMT

Breakthrough discovery reveals treatable form of familial mesothelioma News-Medical

Malignant Mesothelioma: Insights from Prof. Kalemkerian - Oncodaily

Mon, 29 Sep 2025 07:00:00 GMT

Malignant Mesothelioma: Insights from Prof. Kalemkerian Oncodaily

Vanderbilt Minerals Files for Bankruptcy Citing $117.5 Million in Mesothelioma Liabilities - Mesothelioma.net

Mon, 23 Feb 2026 08:00:00 GMT

Vanderbilt Minerals Files for Bankruptcy Citing $117.5 Million in Mesothelioma Liabilities Mesothelioma.net

Pleural mesothelioma - Nature

Thu, 07 Aug 2025 07:00:00 GMT

Pleural mesothelioma Nature

Consensus guideline for the management of peritoneal mesothelioma - Wiley

Wed, 25 Jun 2025 07:00:00 GMT

Consensus guideline for the management of peritoneal mesothelioma Wiley

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours - Yahoo Finance Singapore

Sat, 30 May 2026 18:30:00 GMT

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours Yahoo Finance Singapore

Women and Mesothelioma - Mesothelioma Hub

Thu, 31 Jul 2025 20:44:27 GMT

Women and Mesothelioma Mesothelioma Hub

Mesothelioma Awareness Day - Mesothelioma.net

Thu, 30 Oct 2025 07:00:00 GMT

Mesothelioma Awareness Day Mesothelioma.net

Expanding Viable Tumor-Infiltrating Lymphocytes From Mesothelioma Tumor Tissue - Docwire News

Thu, 10 Jul 2025 07:00:00 GMT

Expanding Viable Tumor-Infiltrating Lymphocytes From Mesothelioma Tumor Tissue Docwire News

Asbestos in Clay Leads to $83 Million Mesothelioma Claim - Mesothelioma Guide

Tue, 07 Oct 2025 07:00:00 GMT

Asbestos in Clay Leads to $83 Million Mesothelioma Claim Mesothelioma Guide

Firefighters & Mesothelioma | Learn the Risks - Mesothelioma Hub

Thu, 31 Jul 2025 20:44:35 GMT

Firefighters & Mesothelioma | Learn the Risks Mesothelioma Hub

Mesothelioma Awareness Month: Honoring Lives, Demanding Action - Asbestos Disease Awareness Organization

Thu, 14 Aug 2025 07:00:00 GMT

Mesothelioma Awareness Month: Honoring Lives, Demanding Action Asbestos Disease Awareness Organization

General Motors Asbestos Lawsuit [2026 Update] - robertkinglawfirm.com

Thu, 18 Dec 2025 08:00:00 GMT

General Motors Asbestos Lawsuit [2026 Update] robertkinglawfirm.com

Claire’s® - Mesothelioma.com

Thu, 23 Oct 2025 20:59:46 GMT

Claire’s® Mesothelioma.com

Oncolytic Virus for Mesothelioma Received Special FDA Status - Mesothelioma Guide

Wed, 25 Jun 2025 07:00:00 GMT

Oncolytic Virus for Mesothelioma Received Special FDA Status Mesothelioma Guide

National Mesothelioma Virtual Bank - Centers for Disease Control and Prevention | CDC (.gov)

Mon, 20 May 2024 07:00:00 GMT

National Mesothelioma Virtual Bank Centers for Disease Control and Prevention | CDC (.gov)

Innovative Mayo Clinic test may improve mesothelioma detection rate in blood - Mayo Clinic News Network

Wed, 06 Nov 2024 08:00:00 GMT

Innovative Mayo Clinic test may improve mesothelioma detection rate in blood Mayo Clinic News Network

Treatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights - ASCO Publications

Fri, 07 Mar 2025 08:00:00 GMT

Treatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights ASCO Publications

USS Bausell (DD-845) and Asbestos - Mesothelioma.net

Tue, 04 Nov 2025 08:00:00 GMT

USS Bausell (DD-845) and Asbestos Mesothelioma.net

Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure - Nature

Thu, 02 Jan 2025 08:00:00 GMT

Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure Nature

Genomic landscape of pleural and peritoneal mesothelioma tumours | British Journal of Cancer - Nature

Thu, 22 Sep 2022 07:00:00 GMT

Genomic landscape of pleural and peritoneal mesothelioma tumours | British Journal of Cancer Nature

Update on biology and management of mesothelioma - ERS - European Respiratory Society

Fri, 25 Oct 2024 18:36:07 GMT

Update on biology and management of mesothelioma ERS - European Respiratory Society

Changing the Game for Treatment & Prevention of Deadly Mesothelioma - Fox Chase Cancer Center

Fri, 15 Dec 2023 11:54:38 GMT

Changing the Game for Treatment & Prevention of Deadly Mesothelioma Fox Chase Cancer Center

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors - Nature

Fri, 03 Nov 2023 07:00:00 GMT

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors Nature

Perspectives on the Treatment of Malignant Pleural Mesothelioma - The New England Journal of Medicine

Wed, 22 Sep 2021 07:00:00 GMT

Perspectives on the Treatment of Malignant Pleural Mesothelioma The New England Journal of Medicine

ASCO Updates Guidelines for Malignant Pleural Mesothelioma Treatment - Targeted Oncology

Wed, 05 Mar 2025 08:00:00 GMT

ASCO Updates Guidelines for Malignant Pleural Mesothelioma Treatment Targeted Oncology

BNT327/PM8002 Plus Chemo Is Active in Unresectable Pleural and Peritoneal Mesothelioma - OncLive

Wed, 04 Jun 2025 07:00:00 GMT

BNT327/PM8002 Plus Chemo Is Active in Unresectable Pleural and Peritoneal Mesothelioma OncLive

Updated Guidelines for Pleural Mesothelioma Highlight New Treatments and Germline Testing - ASCO Daily News

Wed, 08 Jan 2025 08:00:00 GMT

Updated Guidelines for Pleural Mesothelioma Highlight New Treatments and Germline Testing ASCO Daily News

A Rare Cancer: Malignant Mesothelioma - University of Miami

Mon, 20 Nov 2023 08:00:00 GMT

A Rare Cancer: Malignant Mesothelioma University of Miami

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity - Nature

Thu, 16 Mar 2023 07:00:00 GMT

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity Nature

Key Facts & Stats about Mesothelioma Cancer - Mesothelioma Center

Sat, 20 Aug 2016 20:59:33 GMT

Key Facts & Stats about Mesothelioma Cancer Mesothelioma Center

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial - Nature

Mon, 08 Nov 2021 08:00:00 GMT

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial Nature

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel - Nature

Wed, 04 Sep 2019 07:00:00 GMT

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel Nature

Deep learning-based classification of mesothelioma improves prediction of patient outcome - Nature

Mon, 07 Oct 2019 07:00:00 GMT

Deep learning-based classification of mesothelioma improves prediction of patient outcome Nature

First-line Immunotherapy Approved for Advanced Mesothelioma - American Association for Cancer Research (AACR)

Sat, 19 Oct 2024 03:48:35 GMT

First-line Immunotherapy Approved for Advanced Mesothelioma American Association for Cancer Research (AACR)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort - Nature

Mon, 01 Nov 2021 07:00:00 GMT

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort Nature

Diffuse malignant peritoneal mesothelioma: A review - Frontiers

Thu, 27 Jun 2024 08:14:04 GMT

Diffuse malignant peritoneal mesothelioma: A review Frontiers

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial - The Lancet

Fri, 03 Nov 2023 07:00:00 GMT

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial The Lancet

Mesothelioma cancer: still a relevant occupational disease - News articles - Eurostat - European Commission

Thu, 26 Sep 2024 07:00:00 GMT

Mesothelioma cancer: still a relevant occupational disease - News articles - Eurostat European Commission

ASCO25: With BMS on the bispecific bandwagon, BioNTech shares new mesothelioma data - FirstWord Pharma

Tue, 03 Jun 2025 07:00:00 GMT

ASCO25: With BMS on the bispecific bandwagon, BioNTech shares new mesothelioma data FirstWord Pharma

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial - The Lancet

Fri, 10 May 2024 07:00:00 GMT

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial The Lancet

Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells - Nature

Wed, 08 Nov 2023 08:00:00 GMT

Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells Nature

Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment - Nature

Fri, 19 Mar 2021 07:00:00 GMT

Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment Nature